Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Reitsma

Showing results (131-140 of 275) with videos related to

Pageof 28
Sort By:
Blood|February 15, 1989
Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype)P H Reitsma, T Mandalaki, C K Kasper, et al.
Thrombosis and Haemostasis|October 5, 1992
Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNAJ C Eikenboom, H K Ploos van Amstel, P H Reitsma, et al.
Thrombosis and Haemostasis|October 1, 1996
Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutationB Manten, R G Westendorp, T Koster, et al.
Blood|July 1, 1993
Hemophilia B Leyden: substitution of thymine for guanine at position -21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoterM J Reijnen, K Peerlinck, D Maasdam, et al.
British Journal of Haematology|July 1, 1993
Instability of repeats of the von Willebrand factor gene variable number tandem repeat sequence in intron 40J C Eikenboom, P H Reitsma, P A van der Velden, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetesD W Sommeijer, K Joop, A Leyte, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequenceJ C Eikenboom, T Vink, E Briët, et al.
Gut|August 14, 1999
HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysisP C Stokkers, P H Reitsma, G N Tytgat, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 1995
Genotypic variation in the promoter region of the protein C gene is associated with plasma protein C levels and thrombotic riskC A Spek, T Koster, F R Rosendaal, et al.
Advances in Experimental Medicine and Biology|January 1, 1978
A new diphosphonate: dissociation between effects on cells and mineral in rats and a preliminary trial in Paget's diseaseH H Lemkes, P H Reitsma, W Frijlink, et al.
Pageof 28

Showing results (131-140 of 275) with videos related to

Sort By:
Pageof 28
Blood|February 15, 1989
Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype)P H Reitsma, T Mandalaki, C K Kasper, et al.
Thrombosis and Haemostasis|October 5, 1992
Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNAJ C Eikenboom, H K Ploos van Amstel, P H Reitsma, et al.
Thrombosis and Haemostasis|October 1, 1996
Risk factor profiles in patients with different clinical manifestations of venous thromboembolism: a focus on the factor V Leiden mutationB Manten, R G Westendorp, T Koster, et al.
Blood|July 1, 1993
Hemophilia B Leyden: substitution of thymine for guanine at position -21 results in a disruption of a hepatocyte nuclear factor 4 binding site in the factor IX promoterM J Reijnen, K Peerlinck, D Maasdam, et al.
British Journal of Haematology|July 1, 1993
Instability of repeats of the von Willebrand factor gene variable number tandem repeat sequence in intron 40J C Eikenboom, P H Reitsma, P A van der Velden, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2005
Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetesD W Sommeijer, K Joop, A Leyte, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1994
Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequenceJ C Eikenboom, T Vink, E Briët, et al.
Gut|August 14, 1999
HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysisP C Stokkers, P H Reitsma, G N Tytgat, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 1995
Genotypic variation in the promoter region of the protein C gene is associated with plasma protein C levels and thrombotic riskC A Spek, T Koster, F R Rosendaal, et al.
Advances in Experimental Medicine and Biology|January 1, 1978
A new diphosphonate: dissociation between effects on cells and mineral in rats and a preliminary trial in Paget's diseaseH H Lemkes, P H Reitsma, W Frijlink, et al.
Pageof 28